Protease-Activated Receptors (PARs): Biology and Therapeutic Potential in Perioperative Stroke

Transl Stroke Res. 2024 Feb 7. doi: 10.1007/s12975-024-01233-0. Online ahead of print.

Abstract

Perioperative stroke is a devastating complication that occurs during surgery or within 30 days following the surgical procedure. Its prevalence ranges from 0.08 to 10% although it is most likely an underestimation, as sedatives and narcotics can substantially mask symptomatology and clinical presentation. Understanding the underlying pathophysiology and identifying potential therapeutic targets are of paramount importance. Protease-activated receptors (PARs), a unique family of G-protein-coupled receptors, are widely expressed throughout the human body and play essential roles in various physiological and pathological processes. This review elucidates the biology and significance of PARs, outlining their diverse functions in health and disease, and their intricate involvement in cerebrovascular (patho)physiology and neuroprotection. PARs exhibit a dual role in cerebral ischemia, which underscores their potential as therapeutic targets to mitigate the devastating effects of stroke in surgical patients.

Keywords: Anesthesiology; Cardiovascular; Perioperative; Protease-activated Receptors; Stroke; Surgery; Translational Research.

Publication types

  • Review